dextrothyroxine has been researched along with Encephalopathy, Toxic in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Clemons, J; Correia, MS; Hendrickson, RG; Hoang, R; Temple, C | 1 |
| Deepalam, SR; Dsilva, CS; Govindappa, SKG; Kankara, SR; Kumaran, SP; Sarma, GRK; Sharma, VC | 1 |
| Dong, J; Ju, X; Ma, Y; Qiu, L; Wang, C | 1 |
| Chen, AV; Mealey, KL; Poppenga, RH; Talcott, PA; Wright, HM | 1 |
| Eubig, PA; Merola, VM | 1 |
| Jones, YL; Myers, MJ; Orzechowski, KL; Robl, MG; Swaim, HL; Swain, MD; Tinaza, CA; Yancy, HF | 1 |
| Broman, KW; Mealey, KL; Neff, MW; Pedersen, NC; Robertson, KR; Safra, N; Slatkin, M; Wong, AK | 1 |
| Alvinerie, M; Hugnet, C; Lespine, A | 1 |
| Boussinesq, M; Chippaux, JP; Gardon, J; Gardon-Wendel, N; Kamgno, J; Pion, SD | 1 |
2 review(s) available for dextrothyroxine and Encephalopathy, Toxic
| Article | Year |
|---|---|
MRI brain findings of Abamectin toxic encephalopathy: a case report with review of literature.
Topics: Adult; Brain; Female; Humans; Ivermectin; Magnetic Resonance Imaging; Neurotoxicity Syndromes | 2023 |
Toxicology of avermectins and milbemycins (macrocylic lactones) and the role of P-glycoprotein in dogs and cats.
Topics: Animals; Anthelmintics; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breeding; Cat Diseases; Cats; Dog Diseases; Dogs; Ivermectin; Lactones; Macrolides; Neurotoxicity Syndromes | 2012 |
7 other study(ies) available for dextrothyroxine and Encephalopathy, Toxic
| Article | Year |
|---|---|
Characteristics of ivermectin toxicity in patients taking veterinary and human formulations for the prevention and treatment of COVID-19.
Topics: COVID-19; Female; Humans; Ivermectin; Male; Middle Aged; Neurotoxicity Syndromes; Pandemics; Retrospective Studies; Tablets | 2022 |
[Treatment for toxic encephalopathy caused by compound preparation of avermectins and pyridaben].
Topics: Drug Compounding; Ivermectin; Neurotoxicity Syndromes; Pyridazines | 2015 |
Intravenous fat emulsion as treatment for ivermectin toxicosis in three dogs homozygous for the ABCB1-1Δ gene mutation.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Dog Diseases; Dogs; Fat Emulsions, Intravenous; Female; Ivermectin; Male; Mutation; Neurotoxicity Syndromes; Treatment Failure | 2011 |
Neurotoxic effects of ivermectin administration in genetically engineered mice with targeted insertion of the mutated canine ABCB1 gene.
Topics: Animals; Anthelmintics; Ataxia; ATP Binding Cassette Transporter, Subfamily B, Member 1; Dog Diseases; Dogs; Frameshift Mutation; Genotype; Injections, Subcutaneous; Ivermectin; Lethargy; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurotoxicity Syndromes; Real-Time Polymerase Chain Reaction; RNA; Tremor | 2012 |
Breed distribution and history of canine mdr1-1Delta, a pharmacogenetic mutation that marks the emergence of breeds from the collie lineage.
Topics: Alleles; Animals; Breeding; Dog Diseases; Dogs; Gene Frequency; Genes, MDR; Haplotypes; History, Modern 1601-; Ivermectin; Linkage Disequilibrium; Mutation; Neurotoxicity Syndromes; Pharmacogenetics; Phylogeny | 2004 |
Multiple oral dosing of ketoconazole increases dog exposure to ivermectin.
Topics: Administration, Oral; Animals; Antifungal Agents; Antiparasitic Agents; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Chromatography, High Pressure Liquid; Dogs; Drug Administration Schedule; Drug Interactions; Injections, Subcutaneous; Ivermectin; Ketoconazole; Male; Neurotoxicity Syndromes; Random Allocation | 2007 |
Relationships between the prevalence and intensity of Loa loa infection in the Central province of Cameroon.
Topics: Adolescent; Adult; Aged; Animals; Cameroon; Child; Endemic Diseases; Female; Filaricides; Humans; Ivermectin; Loa; Loiasis; Male; Middle Aged; Neurotoxicity Syndromes; Onchocerciasis; Predictive Value of Tests; Prevalence; Sensitivity and Specificity | 2001 |